Headache Characteristics of Patients with COVID-19 in Turkey: Is COVID-19 Infection a Trigger for Migraine Headache?

被引:1
|
作者
Hacioglu, Yalcin [1 ]
Gozubatik-Celik, Rabia Gokcen [2 ]
Yenidunya, Onur [2 ]
Kesmezacar, Ozgu [3 ]
Toprak, Ufuk Emre [4 ]
机构
[1] Univ Hlth Sci, Istanbul Training & Res Hosp, Dept Family Med, Istanbul, Turkiye
[2] Univ Hlth Sci, Bakirkoy Res & Training Hosp Neurol & Psychiat Di, Dept Neurol, Istanbul, Turkiye
[3] Istanbul Prov Hlth Directorate, Dept Stat Anal & Reporting, Istanbul, Turkiye
[4] Univ Hlth Sci, Istanbul Training & Res Hosp, Dept Neurol, Istanbul, Turkiye
来源
关键词
Migraine disorders; patients with COVID-19; primary headache disorders; quality of life score;
D O I
10.29399/npa.28141
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Headache is a common symptom in patients with Coronavirus-19 infection (COVID-19). In this research, we aim to assess the frequency, characteristics, and response to treatment of headache in patients with COVID-19 and its correlation with psychosocial features in Turkey. Methods: To describe the clinical features of headache in COVID-19 positive individuals. Patients were evaluated and followed up with face-to-face visits in a tertiary hospital during the pandemic period. Results: One hundred and seventeen of 150 patients (78%) had a headache diagnosed before and during the pandemic, 62 of 150 (41.3%) had a new type of headache. No significant differences were observed in terms of demographics, Beck Depression Score, Beck Anxiety Score, and quality of life scales (QOLS) between patients with and without headache (p>0.05). The most common triggering factor for headache was stress and fatigue in 59% (n=69), while the second most common (32.4%, n=38) was COVID-19 infection. 46.5% of the patients reported that the severity and frequency of their current headaches increased after the COVID-19 infection. Among new-onset headaches, the social functionality and pain score subgroups of the QOLS form were significantly lower in housewives and unemployed patients compared to the working group (p=0.018; p=0.039 respectively). Twelve of 117 patients had a mild to moderate, throbbing headache in the temporoparietal region, which did not fulfill the International Classification of Headache Disorders diagnosis criteria, but showed as a common feature among COVID-19 patients. Nineteen of 62 patients (30.9%) had a newly diagnosed migraine syndrome. Conclusion: The diagnosis incidence of migraine in patients with COVID-19 disease being more than other headaches types may suggest the existence of a common pathway in possible immune mechanisms.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 50 条
  • [21] Headache prevalence in COVID-19 ambulatory patients
    NInashvili, N.
    Shavdia, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 74 - 74
  • [22] The characteristics of COVID-19 vaccine-related headache
    Ekizoglu, E.
    Gezegen, H.
    Dikmen, P. Yalinay
    Orhan, E. Kocasoy
    Ertas, M.
    Baykan, B.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 5 - 5
  • [23] The characteristics of COVID-19 vaccine-related headache
    Ekizoglu, E.
    Gezegen, H.
    Dikmen, P. Yalinay
    Orhan, E. Kocasoy
    Ertas, M.
    Baykan, B.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 7 - 7
  • [24] COVID-19 related headache and its clinical characteristics
    Barut, Banu Ozen
    Ulutas, Samiye
    Sahbaz, Gulhan
    Celik, Afra
    Kara, Tugce Sule
    Ongoru, Pinar
    NEUROLOGY ASIA, 2021, 26 (01) : 101 - 106
  • [25] Headache and COVID-19 Vaccination: data from online questionnaire in patients with migraine
    Orologio, I.
    Silvestro, M.
    Sozio, P.
    Napolitano, G.
    Tessitore, A.
    Tedeschi, G.
    Russo, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 739 - 739
  • [26] Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic
    Ma, Mengmeng
    Bao, Jiajia
    Fang, Jinghuan
    Li, Changling
    Li, Yanbo
    Ge, Wenjing
    Zhang, Yang
    Guo, Jian
    He, Li
    CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (01) : 4 - 11
  • [27] Virtual issue: COVID-19 and headache
    Caronna, Edoardo
    Pozo-Rosich, Patricia
    HEADACHE, 2023, 63 (02): : 183 - 184
  • [28] Case report: Headache and COVID-19
    Xhelili, M.
    Zekja, I.
    Kruja, J.
    Rroji, A.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [29] Headache medication and the COVID-19 pandemic
    Antoinette MaassenVanDenBrink
    Tessa de Vries
    A. H. Jan Danser
    The Journal of Headache and Pain, 2020, 21
  • [30] Virtual Issue: COVID-19 and headache
    Bobker, Sarah M.
    Robbins, Matthew S.
    HEADACHE, 2021, 61 (03): : 412 - 413